Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1’350 INR | -0.48% | +2.69% | -0.42% |
Kurzporträt
Mitarbeiterzahl: 1 642
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 12 694 | 100,0 % | 14 667 | 100,0 % | +15.54% |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Latin America
83,0
%
| 11 381 | 87,0 % | 12 638 | 83,0 % | +11.05% |
United States
14,0
%
| 1 308 | 10,0 % | 2 132 | 14,0 % | +62.96% |
Africa
3,0
%
| 392 | 3,0 % | 457 | 3,0 % | +16.40% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28.03.15 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19.02.16 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Gunasakaran S.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Umesh Setty V.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25.06.22 | |
Chief Operating Officer | - | 01.12.10 | |
Umapathy V.
LAW | General Counsel | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 01.12.10 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28.03.15 |
Director/Board Member | 64 | 09.11.16 | |
C. K. Gariyali
BRD | Director/Board Member | 75 | 04.03.20 |
R. Nagendran
BRD | Director/Board Member | - | - |
S Deenadhayalan
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 75 941 746 | 19 238 423 ( 25,33 %) | 0 | 25,33 % |
Unternehmenskontakt
Caplin Point Laboratories Ltd.
Ashvich Tower Developed Plots Industrial Estate
600096, Chennai
+91 44 2496 8000
http://www.caplinpoint.netKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Caplin Steriles Ltd.
Caplin Steriles Ltd. Pharmaceuticals: MajorHealth Technology Caplin Steriles Ltd. manufactures and sells injectable pharmaceutical products. The company was founded on December 12, 2018 and is headquartered in Chennai, India. |
Pharmaceuticals: Major
|
Caplin Onco Ltd.
|
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
-0.42% | 1.23 Mrd. | |
+19.62% | 43.34 Mrd. | |
+20.44% | 21.96 Mrd. | |
+10.86% | 14.09 Mrd. | |
+13.07% | 13.64 Mrd. | |
+37.46% | 11.43 Mrd. | |
-8.59% | 6.86 Mrd. | |
-0.05% | 6.79 Mrd. | |
-8.87% | 5.73 Mrd. | |
+8.46% | 5.22 Mrd. |
- Börse
- Aktien
- A2DSTM Aktie
- Unternehmen Caplin Point Laboratories Limited